Review





Similar Products

90
Seca 213 precision measuring instrument
213 Precision Measuring Instrument, supplied by Seca, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/213/213+precision+measuring+instrument/nct06317883-40-9-9
Average 90 stars, based on 1 article reviews
213 precision measuring instrument - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

daudi  (ATCC)
98
ATCC daudi
(A) Surface plasmon resonance (SPR) sensorgrams showing the binding kinetics of recombinant CD22-His protein to immobilized anti-CD22 monoclonal antibody clones (24A7G6, 29H9C8, 36B1E12, and 37B7G12) coated at 0.5 µg/mL. CD22 analytes were injected at concentrations of 1.645, 3.290, 6.580, 13.16, and 26.23 nM. Distinct association and dissociation profiles indicate differences in binding kinetics and affinities among the clones. (B) Flow cytometry analysis of antibody binding specificity to human cell lines expressing various levels of CD22. <t>Daudi</t> and <t>Raji</t> (CD22 ⁺ B-cell lines), Molt-4 (T-cell line), and THP-1 (monocytic line) were stained with each anti-CD22 clone or isotype control. Representative histograms are shown, with mean fluorescence intensity (MFI) values indicating CD22-binding strength. (C) Structural modeling of CD22–antibody interactions predicted by AlphaFold. The seven extracellular immunoglobulin-like domains of CD22 (D1–D7) are illustrated (left). Predicted domain-binding sites of each anti-CD22 clone (24A7G6, 29H9C8, 36B1E12, and 37B7G12) are depicted in complex with their variable heavy (VH) and variable light (VL) chain regions (right).
Daudi, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/213/Daudi/pmc13759115-39-12-20
Average 98 stars, based on 1 article reviews
daudi - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

99
Danaher Inc 213 thunder imager 3d assay platform
(A) Surface plasmon resonance (SPR) sensorgrams showing the binding kinetics of recombinant CD22-His protein to immobilized anti-CD22 monoclonal antibody clones (24A7G6, 29H9C8, 36B1E12, and 37B7G12) coated at 0.5 µg/mL. CD22 analytes were injected at concentrations of 1.645, 3.290, 6.580, 13.16, and 26.23 nM. Distinct association and dissociation profiles indicate differences in binding kinetics and affinities among the clones. (B) Flow cytometry analysis of antibody binding specificity to human cell lines expressing various levels of CD22. <t>Daudi</t> and <t>Raji</t> (CD22 ⁺ B-cell lines), Molt-4 (T-cell line), and THP-1 (monocytic line) were stained with each anti-CD22 clone or isotype control. Representative histograms are shown, with mean fluorescence intensity (MFI) values indicating CD22-binding strength. (C) Structural modeling of CD22–antibody interactions predicted by AlphaFold. The seven extracellular immunoglobulin-like domains of CD22 (D1–D7) are illustrated (left). Predicted domain-binding sites of each anti-CD22 clone (24A7G6, 29H9C8, 36B1E12, and 37B7G12) are depicted in complex with their variable heavy (VH) and variable light (VL) chain regions (right).
213 Thunder Imager 3d Assay Platform, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/213/THUNDER+Imager+Live+Cell+%26+3D+Assay/pm42988297-121-18-17
Average 99 stars, based on 1 article reviews
213 thunder imager 3d assay platform - by Bioz Stars, 2026-11
99/100 stars
  Buy from Supplier

96
Novus Biologicals chicken anti map2
(A) Surface plasmon resonance (SPR) sensorgrams showing the binding kinetics of recombinant CD22-His protein to immobilized anti-CD22 monoclonal antibody clones (24A7G6, 29H9C8, 36B1E12, and 37B7G12) coated at 0.5 µg/mL. CD22 analytes were injected at concentrations of 1.645, 3.290, 6.580, 13.16, and 26.23 nM. Distinct association and dissociation profiles indicate differences in binding kinetics and affinities among the clones. (B) Flow cytometry analysis of antibody binding specificity to human cell lines expressing various levels of CD22. <t>Daudi</t> and <t>Raji</t> (CD22 ⁺ B-cell lines), Molt-4 (T-cell line), and THP-1 (monocytic line) were stained with each anti-CD22 clone or isotype control. Representative histograms are shown, with mean fluorescence intensity (MFI) values indicating CD22-binding strength. (C) Structural modeling of CD22–antibody interactions predicted by AlphaFold. The seven extracellular immunoglobulin-like domains of CD22 (D1–D7) are illustrated (left). Predicted domain-binding sites of each anti-CD22 clone (24A7G6, 29H9C8, 36B1E12, and 37B7G12) are depicted in complex with their variable heavy (VH) and variable light (VL) chain regions (right).
Chicken Anti Map2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/213/MAP2+Antibody/bio_rxiv__64898__2026__11__04__764401-368-80-82
Average 96 stars, based on 1 article reviews
chicken anti map2 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Mini-Circuits broadband low noise amplifier
(A) Surface plasmon resonance (SPR) sensorgrams showing the binding kinetics of recombinant CD22-His protein to immobilized anti-CD22 monoclonal antibody clones (24A7G6, 29H9C8, 36B1E12, and 37B7G12) coated at 0.5 µg/mL. CD22 analytes were injected at concentrations of 1.645, 3.290, 6.580, 13.16, and 26.23 nM. Distinct association and dissociation profiles indicate differences in binding kinetics and affinities among the clones. (B) Flow cytometry analysis of antibody binding specificity to human cell lines expressing various levels of CD22. <t>Daudi</t> and <t>Raji</t> (CD22 ⁺ B-cell lines), Molt-4 (T-cell line), and THP-1 (monocytic line) were stained with each anti-CD22 clone or isotype control. Representative histograms are shown, with mean fluorescence intensity (MFI) values indicating CD22-binding strength. (C) Structural modeling of CD22–antibody interactions predicted by AlphaFold. The seven extracellular immunoglobulin-like domains of CD22 (D1–D7) are illustrated (left). Predicted domain-binding sites of each anti-CD22 clone (24A7G6, 29H9C8, 36B1E12, and 37B7G12) are depicted in complex with their variable heavy (VH) and variable light (VL) chain regions (right).
Broadband Low Noise Amplifier, supplied by Mini-Circuits, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/213/Coaxial+Medium+Power+Amplifiers/pm42980940-62-1-7
Average 96 stars, based on 1 article reviews
broadband low noise amplifier - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

96
Novus Biologicals map2
(A) Increased tau phosphorylation in dendrites <t>(MAP2+)</t> with 20 µm bicuculline treatment. (B) Schema of hippocampal excitatory neuron subtyping for colocalization with phospho-tau. (C) Increased tau phosphorylation at S202/T205 is induced by bicuculline specifically in excitatory pyramidal neurons (NeuroD6+) but not altered by TTX. (D) pT231 tau phosphorylation is not altered by changes in neuronal activity. Bic, bicuculline; TTX, tetrodotoxin. Scale bar is 25 µm. Neurons quantified in each condition are indicated in
Map2, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/213/MAP2+Antibody/bio_rxiv__64898__2026__10__26__762028-36-33-35
Average 96 stars, based on 1 article reviews
map2 - by Bioz Stars, 2026-11
96/100 stars
  Buy from Supplier

98
ATCC daudi cell lines
T-BET promotes IFNγ production without enhancing cytotoxic function in iNK cells (A) Degranulation activity measured by CD107a expression in iNK CTRL, iNK T-BET/OE, and primary NK (pNK) cells following co-culture with target <t>cells</t> <t>(K562,</t> RAJI, RAJI + RTX, <t>DAUDI)</t> or stimulation with PMA/ionomycin. (B) Cytotoxic activity assessed by specific lysis of target cells labelled with chromium-51 at indicated effector-to-target (E:T) ratios. Šídák’s multiple comparisons test identified a statistically significant difference only between iNK CTRL and pNK at an E:T ratio of 0.3:1 ( P < 0.05); no other pairwise comparisons reached statistical significance. (C) IFNγ production in iNK CTRL, iNK T-BET/OE, and pNK cells following stimulation with target cells or PMA/ionomycin. Data are shown as mean ± SD. iNK CTRL, N = 3 independent differentiations of one engineered iPSC line; iNK T-BET/OE, N = 3 independent differentiations of one engineered iPSC line; pNK, N = 4 healthy donors. Overall statistical significance determined by the two-way repeated-measures ANOVA is reported below the graph. Statistically significant pairwise comparisons identified by Šídák’s multiple comparisons test are indicated by asterisks as follows: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).
Daudi Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 98/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/213/Daudi/pmc13749396-42-3-9
Average 98 stars, based on 1 article reviews
daudi cell lines - by Bioz Stars, 2026-11
98/100 stars
  Buy from Supplier

94
Cell Applications Inc endothelial cell growth medium v2
T-BET promotes IFNγ production without enhancing cytotoxic function in iNK cells (A) Degranulation activity measured by CD107a expression in iNK CTRL, iNK T-BET/OE, and primary NK (pNK) cells following co-culture with target <t>cells</t> <t>(K562,</t> RAJI, RAJI + RTX, <t>DAUDI)</t> or stimulation with PMA/ionomycin. (B) Cytotoxic activity assessed by specific lysis of target cells labelled with chromium-51 at indicated effector-to-target (E:T) ratios. Šídák’s multiple comparisons test identified a statistically significant difference only between iNK CTRL and pNK at an E:T ratio of 0.3:1 ( P < 0.05); no other pairwise comparisons reached statistical significance. (C) IFNγ production in iNK CTRL, iNK T-BET/OE, and pNK cells following stimulation with target cells or PMA/ionomycin. Data are shown as mean ± SD. iNK CTRL, N = 3 independent differentiations of one engineered iPSC line; iNK T-BET/OE, N = 3 independent differentiations of one engineered iPSC line; pNK, N = 4 healthy donors. Overall statistical significance determined by the two-way repeated-measures ANOVA is reported below the graph. Statistically significant pairwise comparisons identified by Šídák’s multiple comparisons test are indicated by asterisks as follows: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).
Endothelial Cell Growth Medium V2, supplied by Cell Applications Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/213/Human+Endothelial+Cell+Media+v2/pm42929833-69-17-22
Average 94 stars, based on 1 article reviews
endothelial cell growth medium v2 - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

Image Search Results


(A) Surface plasmon resonance (SPR) sensorgrams showing the binding kinetics of recombinant CD22-His protein to immobilized anti-CD22 monoclonal antibody clones (24A7G6, 29H9C8, 36B1E12, and 37B7G12) coated at 0.5 µg/mL. CD22 analytes were injected at concentrations of 1.645, 3.290, 6.580, 13.16, and 26.23 nM. Distinct association and dissociation profiles indicate differences in binding kinetics and affinities among the clones. (B) Flow cytometry analysis of antibody binding specificity to human cell lines expressing various levels of CD22. Daudi and Raji (CD22 ⁺ B-cell lines), Molt-4 (T-cell line), and THP-1 (monocytic line) were stained with each anti-CD22 clone or isotype control. Representative histograms are shown, with mean fluorescence intensity (MFI) values indicating CD22-binding strength. (C) Structural modeling of CD22–antibody interactions predicted by AlphaFold. The seven extracellular immunoglobulin-like domains of CD22 (D1–D7) are illustrated (left). Predicted domain-binding sites of each anti-CD22 clone (24A7G6, 29H9C8, 36B1E12, and 37B7G12) are depicted in complex with their variable heavy (VH) and variable light (VL) chain regions (right).

Journal: PLOS One

Article Title: Generation and in vitro functional characterization of anti-CD22 chimeric antigen receptor T cells derived from newly generated monoclonal antibody clones

doi: 10.1371/journal.pone.0362221

Figure Lengend Snippet: (A) Surface plasmon resonance (SPR) sensorgrams showing the binding kinetics of recombinant CD22-His protein to immobilized anti-CD22 monoclonal antibody clones (24A7G6, 29H9C8, 36B1E12, and 37B7G12) coated at 0.5 µg/mL. CD22 analytes were injected at concentrations of 1.645, 3.290, 6.580, 13.16, and 26.23 nM. Distinct association and dissociation profiles indicate differences in binding kinetics and affinities among the clones. (B) Flow cytometry analysis of antibody binding specificity to human cell lines expressing various levels of CD22. Daudi and Raji (CD22 ⁺ B-cell lines), Molt-4 (T-cell line), and THP-1 (monocytic line) were stained with each anti-CD22 clone or isotype control. Representative histograms are shown, with mean fluorescence intensity (MFI) values indicating CD22-binding strength. (C) Structural modeling of CD22–antibody interactions predicted by AlphaFold. The seven extracellular immunoglobulin-like domains of CD22 (D1–D7) are illustrated (left). Predicted domain-binding sites of each anti-CD22 clone (24A7G6, 29H9C8, 36B1E12, and 37B7G12) are depicted in complex with their variable heavy (VH) and variable light (VL) chain regions (right).

Article Snippet: The following cell lines were used: Raji (RRID:CVCL_2699), Nalm-6 (RRID:CVCL_0092), K562 (RRID:CVCL_0004), Daudi (RRID:CVCL_0008), Molt-4 (RRID:CVCL_0013), THP-1 (RRID:CVCL_0006), and 293T (ATCC:CRL_3216).

Techniques: SPR Assay, Binding Assay, Recombinant, Clone Assay, Injection, Flow Cytometry, Analysis, Expressing, Staining, Control, Fluorescence

(A) Increased tau phosphorylation in dendrites (MAP2+) with 20 µm bicuculline treatment. (B) Schema of hippocampal excitatory neuron subtyping for colocalization with phospho-tau. (C) Increased tau phosphorylation at S202/T205 is induced by bicuculline specifically in excitatory pyramidal neurons (NeuroD6+) but not altered by TTX. (D) pT231 tau phosphorylation is not altered by changes in neuronal activity. Bic, bicuculline; TTX, tetrodotoxin. Scale bar is 25 µm. Neurons quantified in each condition are indicated in

Journal: bioRxiv

Article Title: Neuronal Hyperactivity Induces Tau Phosphorylation Selectively in Excitatory Pyramidal Neurons Which Contributes to GluA2 Regulation

doi: 10.64898/2026.10.26.762028

Figure Lengend Snippet: (A) Increased tau phosphorylation in dendrites (MAP2+) with 20 µm bicuculline treatment. (B) Schema of hippocampal excitatory neuron subtyping for colocalization with phospho-tau. (C) Increased tau phosphorylation at S202/T205 is induced by bicuculline specifically in excitatory pyramidal neurons (NeuroD6+) but not altered by TTX. (D) pT231 tau phosphorylation is not altered by changes in neuronal activity. Bic, bicuculline; TTX, tetrodotoxin. Scale bar is 25 µm. Neurons quantified in each condition are indicated in

Article Snippet: Primary antibodies and dilutions used in this study were 1:1000 total tau (ab76128, Abcam, Cambridge, UK), 1:1000 phospho-tau S202/T205 (MN1020, ThermoFisher, Waltham, MA, USA), 1:1000 phosphotau T231 (MN1040, ThermoFisher, Waltham, MA, USA), 1:1000 MAP2 (NB300-213, Novus Biologicals, Centennial, CO, USA), 1:400 CTIP2 (AB18465, Abcam, Cambridge, UK), 1:400 NeuroD6 (AB85824, Abcam, Cambridge, UK), 1:150 GAD67 (sc28376, Santa Cruz Biotechnology, Dallas, TX, USA), 1:2000 GFP (ab13970, Abcam, Cambridge, UK), 1:2000 Myc (clone 2235, Huganir lab), 1:1000 GluA2 (purified 15F1, Gouaux lab( )), and 1:500 cfos (226008, Synaptic Systems, Göttingen, Germany).

Techniques: Phospho-proteomics, Activity Assay

T-BET promotes IFNγ production without enhancing cytotoxic function in iNK cells (A) Degranulation activity measured by CD107a expression in iNK CTRL, iNK T-BET/OE, and primary NK (pNK) cells following co-culture with target cells (K562, RAJI, RAJI + RTX, DAUDI) or stimulation with PMA/ionomycin. (B) Cytotoxic activity assessed by specific lysis of target cells labelled with chromium-51 at indicated effector-to-target (E:T) ratios. Šídák’s multiple comparisons test identified a statistically significant difference only between iNK CTRL and pNK at an E:T ratio of 0.3:1 ( P < 0.05); no other pairwise comparisons reached statistical significance. (C) IFNγ production in iNK CTRL, iNK T-BET/OE, and pNK cells following stimulation with target cells or PMA/ionomycin. Data are shown as mean ± SD. iNK CTRL, N = 3 independent differentiations of one engineered iPSC line; iNK T-BET/OE, N = 3 independent differentiations of one engineered iPSC line; pNK, N = 4 healthy donors. Overall statistical significance determined by the two-way repeated-measures ANOVA is reported below the graph. Statistically significant pairwise comparisons identified by Šídák’s multiple comparisons test are indicated by asterisks as follows: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).

Journal: Frontiers in Pharmacology

Article Title: T-BET promotes inflammatory specialization without driving terminal maturation of iPSC-derived NK cells

doi: 10.3389/fphar.2026.1952429

Figure Lengend Snippet: T-BET promotes IFNγ production without enhancing cytotoxic function in iNK cells (A) Degranulation activity measured by CD107a expression in iNK CTRL, iNK T-BET/OE, and primary NK (pNK) cells following co-culture with target cells (K562, RAJI, RAJI + RTX, DAUDI) or stimulation with PMA/ionomycin. (B) Cytotoxic activity assessed by specific lysis of target cells labelled with chromium-51 at indicated effector-to-target (E:T) ratios. Šídák’s multiple comparisons test identified a statistically significant difference only between iNK CTRL and pNK at an E:T ratio of 0.3:1 ( P < 0.05); no other pairwise comparisons reached statistical significance. (C) IFNγ production in iNK CTRL, iNK T-BET/OE, and pNK cells following stimulation with target cells or PMA/ionomycin. Data are shown as mean ± SD. iNK CTRL, N = 3 independent differentiations of one engineered iPSC line; iNK T-BET/OE, N = 3 independent differentiations of one engineered iPSC line; pNK, N = 4 healthy donors. Overall statistical significance determined by the two-way repeated-measures ANOVA is reported below the graph. Statistically significant pairwise comparisons identified by Šídák’s multiple comparisons test are indicated by asterisks as follows: p < 0.05 (*), p < 0.01 (**), p < 0.001 (***), p < 0.0001 (****).

Article Snippet: K562, Raji, and Daudi cell lines were obtained from ATCC.

Techniques: Activity Assay, Expressing, Co-culture Assay, Lysis